Home › Peripheral Arterial Disease › NCT06308562
Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease
Recruiting
A Pilot Study of Fuzzy Wale Compression Stockinet to Evaluate Healing Following Transtibial Amputation for Peripheral Arterial Disease
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * \>18 years * Male and female * Transtibial amputation expected. * Peripheral arterial disease and Transcutaneous partial pressure of oxygen (TCP02, if performed) * Ability of subject to give appropriate consent or have an appropriate representative available to do so. Exclusion Criteria: * Known allergies to any of the components of the compression. * Terminal illness or current cancer therapy with chemotherapy * Inability to undergo ongoing care in Rochester. * Lack of cognitive ability to follow instructions or monitor residual limb. * Vulnerable study population * Pregnancy
About the study
The objective of this study is to determine if using Fuzzy Wale compression stockinet can assist in reducing the healing time and decrease costs in transtibial amputation patients as compared to standard of care treatment compression stocking.
What is being tested
- Fuzzy Wale Compression Stockinet (device)
Sponsor: Mayo Clinic · Participants: 40 · Started: Jul 7, 2025
Contact the study team
- Vascular Research Team · Phone: (507) 538-7425
- Matthew Melin, M.D. · Phone: (507) 266-6717
Official record on ClinicalTrials.gov — NCT06308562
Locations in the U.S.
| Minnesota | Mayo Clinic, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.